Usa Financial Portformulas Corp Adma Biologics, Inc. Transaction History
Usa Financial Portformulas Corp
- $616 Million
- Q2 2024
A detailed history of Usa Financial Portformulas Corp transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Usa Financial Portformulas Corp holds 6,278 shares of ADMA stock, worth $125,497. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,278Holding current value
$125,497% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
265Shares Held
178MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$373 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$290 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$263 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$178 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$161 Million0.0% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.93B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...